Overview & Products Founded Year1999 About AstraZeneca US AstraZeneca US is a biopharmaceutical company focused on developing and delivering life-changing medicines. The company's main offerings include innovative treatments for a range of conditions, including oncology, respiratory diseases, and ...
AstraZeneca is a global, innovation-driven biopharmaceutical business that discovers, develops, and commercializes prescription medicines. Its primary focus areas are cardiovascular, renal, and metabolic diseases, oncology, respiratory diseases, inflammation and autoimmunity, infection and vaccines, and neurosci...
We invest in distinctive science in three main therapy areas where we can make the most meaningful difference: oncology; cardiovascular and metabolic disease; and respiratory, inflammation and autoimmunity. As a global, innovation-driven pharmaceutical company that spans discovery, development, ...
The company offers a range of life-saving vaccines and treatments for conditions in immunology, oncology, neurology, rare blood disorders, and rare diseases, as well as consumer healthcare products. Sanofi's products are designed to improve people's lives by addressing complex medical challenges ...
AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. It has a range of medicines that includes treatments for illnesses, such as its antibiotic, Merrem/...
Products and Services ProductsBrands Oncology: Accolate Calquence: Acalabrutinib Arimidex Enhertu: Trastuzumab Deruxtecan Atacand XYZ XYZ XYZ XYZ XYZ XYZ Understand AstraZeneca Plc portfolio and identify potential areas for collaboration Register your interest Competitor Comparison Key ParametersAstraZen...
AstraZeneca Oncology Business Unit executive vice-president Dave Fredrickson said: “The rapid approval of Enhertu in HER2-low metastatic breast cancer by the FDA underscores the urgency to bring this transformational medicine to patients as quickly as possible. ...
Products or Services AstraZeneca Thailand focuses on the discovery, development, and commercialisation of prescription medicines and vaccines in four therapy areas: Oncology, Cardiovascular, Renal and Metabolism (CVRM), Respiratory, Immunology, Vaccines, and Immune Therapies (RIVIT) and Rare Disease. Owne...
AstraZeneca Oncology business unit executive vice-president Dave Fredrickson said: “Today’s approval of Imfinzi plus chemotherapy brings an important global standard of care to patients with extensive-stage small-cell lung cancer in China, who have had few treatment options and a dire prognosis. ...
It offers a range of life-saving vaccines and therapeutic treatments for conditions in immunology, oncology, neurology, rare blood disorders, and rare diseases, as well as consumer healthcare products. Its products are designed to improve people's lives by addressing complex medical challenges and ...